Dimethyl Fumarate

CD4 molecule ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34345437 A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment. 2021 Jul-Sep 2
2 34849598 Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity. 2021 Nov 29 1
3 31675639 Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis. 2020 Jan 3
4 32371548 Dimethyl fumarate suppresses granulocyte macrophage colony-stimulating factor-producing Th1 cells in CNS neuroinflammation. 2020 Jul 1
5 32440353 Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis. 2020 Apr-Jun 1
6 31066225 Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment. 2019 Sep 1
7 30038789 DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate. 2018 Jul-Sep 2
8 30263146 The effect of disease modifying therapies on CD62L expression in multiple sclerosis. 2018 Jul-Sep 1
9 28258191 Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients. 2017 Apr 15 3
10 28377940 Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis. 2017 May 5
11 29141823 Delayed lymphocyte re-population following discontinuation of dimethyl fumarate and after switching to other disease modifying drug therapies. 2017 Nov 3
12 26767188 Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis. 2016 Feb 6